[Treatment results in children with B-cell lymphomas using a modified BFM protocol].
Trial of the modified protocol BFM in the treatment of children with B-cell lymphomas. 26 children with B-cell lymphoma were treated. Of them 2 children were treated according to the program for risk 2 group and 24 children were treated as risk 3 group. Complete remission was achieved in 23 patients. Two children were resistant. There were 2 cases of early recurrence, 1 case of early death, 1 case of death in remission. 20 patients are in complete remission. The 4-year survival is 78%. The modified protocol BFM proved to be highly effective against B-cell lymphoma in children. Its drawback is high toxicity.